Phase 1/2 study of Proteostasis PTI-801-01

[jricci]

This study is for people 18 years or older who have two copies of the F508del CFTR mutation and have been taking lumacaftor/ivacaftor for at least three months.

https://clinicaltrials.gov/ct2/show/NCT03140527?term=Proteostasis&cond=Cystic+Fibrosis&rank=2